SHEILA BONIN: Open Payments
NPI 1376581165 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 11 payments from 5 companies in 2025. Trend: 2023 $73 · 2024 $190 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $107 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Organon LLC | 1 | $19 |
| MILLICENT US INC | 1 | $14 |
Products named: Veozah, LYNPARZA, KEYTRUDA, NEXPLANON, INTRAROSA.
Industry payments across LA — which companies pay providers there.
